Literature DB >> 24223609

Modulation of Estrogen Chemical Carcinogenesis by Botanical Supplements used for Postmenopausal Women's Health.

Courtney S Snelten1, Birgit Dietz, Judy L Bolton.   

Abstract

Breast cancer risk has been associated with long-term estrogen exposure including traditional hormone therapy (HT, formally hormone replacement therapy). To avoid traditional HT and associated risks, women have been turning to botanical supplements such as black cohosh, red clover, licorice, hops, dong gui, and ginger to relieve menopausal symptoms despite a lack of efficacy evidence. The mechanisms of estrogen carcinogenesis involve both hormonal and chemical pathways. Botanical supplements could protect women from estrogen carcinogenesis by modulating key enzymatic steps [aromatase, P4501B1, P4501A1, catechol-O-methyltransferase (COMT), NAD(P)H quinone oxidoreductase 1 (NQO1), and reactive oxygen species (ROS) scavenging] in estradiol metabolism leading to estrogen carcinogenesis as outlined in Figure 1. This review summarizes the influence of popular botanical supplements used for women's health on these key steps in the estrogen chemical carcinogenesis pathway, and suggests that botanical supplements may have added chemopreventive benefits by modulating estrogen metabolism.

Entities:  

Year:  2012        PMID: 24223609      PMCID: PMC3818722          DOI: 10.1016/j.ddmec.2012.11.001

Source DB:  PubMed          Journal:  Drug Discov Today Dis Mech        ISSN: 1740-6765


  65 in total

Review 1.  Alternative and complementary therapies for the menopause.

Authors:  Francesca Borrelli; Edzard Ernst
Journal:  Maturitas       Date:  2010-06-30       Impact factor: 4.342

2.  Expression of estrogen receptor beta isoforms in human breast cancer tissues and cell lines.

Authors:  Dan Tong; Eva Schuster; Michael Seifert; Klaus Czerwenka; Sepp Leodolte; Robert Zeillinger
Journal:  Breast Cancer Res Treat       Date:  2002-02       Impact factor: 4.872

3.  Catechol-O-methyltransferase-mediated metabolism of 4-hydroxyestradiol inhibits the growth of human renal cancer cells through the apoptotic pathway.

Authors:  Inik Chang; Jan Liu; Shahana Majid; Sharanjot Saini; Mohd S Zaman; Soichiro Yamamura; Varahram Shahryari; Takeshi Chiyomaru; Guoren Deng; Rajvir Dahiya; Yuichiro Tanaka
Journal:  Carcinogenesis       Date:  2011-12-09       Impact factor: 4.944

4.  Anti-inflammatory/Anti-oxidative stress activities and differential regulation of Nrf2-mediated genes by non-polar fractions of tea Chrysanthemum zawadskii and licorice Glycyrrhiza uralensis.

Authors:  Tien-Yuan Wu; Tin Oo Khor; Constance Lay Lay Saw; Stephanie C Loh; Alvin I Chen; Soon Sung Lim; Jung Han Yoon Park; Li Cai; Ah-Ng Tony Kong
Journal:  AAPS J       Date:  2010-10-22       Impact factor: 4.009

Review 5.  The different roles of ER subtypes in cancer biology and therapy.

Authors:  Christoforos Thomas; Jan-Åke Gustafsson
Journal:  Nat Rev Cancer       Date:  2011-07-22       Impact factor: 60.716

6.  Two glutathione S-transferase inhibitors from Radix Angelicae sinensis.

Authors:  Feng Huang; Shaojing Li; Xinhua Lu; Ailin Liu; Guanhua Du; Ganggang Shi
Journal:  Phytother Res       Date:  2011-02       Impact factor: 5.878

7.  The red clover (Trifolium pratense) isoflavone biochanin A inhibits aromatase activity and expression.

Authors:  Yun Wang; Wai Man Gho; Franky L Chan; Shiuan Chen; Lai K Leung
Journal:  Br J Nutr       Date:  2007-08-29       Impact factor: 3.718

8.  Aromatase inhibition by synthetic lactones and flavonoids in human placental microsomes and breast fibroblasts--a comparative study.

Authors:  J A van Meeuwen; S Nijmeijer; T Mutarapat; S Ruchirawat; P C de Jong; A H Piersma; M van den Berg
Journal:  Toxicol Appl Pharmacol       Date:  2007-12-14       Impact factor: 4.219

9.  Cancer chemopreventive activity and metabolism of isoliquiritigenin, a compound found in licorice.

Authors:  Muriel Cuendet; Jian Guo; Yan Luo; Shaonong Chen; Carol P Oteham; Richard C Moon; Richard B van Breemen; Laura E Marler; John M Pezzuto
Journal:  Cancer Prev Res (Phila)       Date:  2010-01-12

10.  Expression of estrogenicity genes in a lineage cell culture model of human breast cancer progression.

Authors:  Jiaqi Fu; Amy M Weise; Josie L Falany; Charles N Falany; Bryan J Thibodeau; Fred R Miller; Thomas A Kocarek; Melissa Runge-Morris
Journal:  Breast Cancer Res Treat       Date:  2009-03-24       Impact factor: 4.872

View more
  6 in total

1.  Preface.

Authors:  Ercole Cavalieri; Eleanor G Rogan
Journal:  Drug Discov Today Dis Mech       Date:  2012-12-22

2.  Differential Effects of Glycyrrhiza Species on Genotoxic Estrogen Metabolism: Licochalcone A Downregulates P450 1B1, whereas Isoliquiritigenin Stimulates It.

Authors:  Tareisha L Dunlap; Shuai Wang; Charlotte Simmler; Shao-Nong Chen; Guido F Pauli; Birgit M Dietz; Judy L Bolton
Journal:  Chem Res Toxicol       Date:  2015-07-16       Impact factor: 3.739

Review 3.  Botanicals and Their Bioactive Phytochemicals for Women's Health.

Authors:  Birgit M Dietz; Atieh Hajirahimkhan; Tareisha L Dunlap; Judy L Bolton
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

4.  The effects of black cohosh on the regulation of estrogen receptor (ERα) and progesterone receptor (PR) in breast cancer cells.

Authors:  Monica Szmyd; Victoria Lloyd; Kelly Hallman; Katie Aleck; Viktoria Mladenovik; Christina McKee; Mia Morse; Tyler Bedgood; Sumi Dinda
Journal:  Breast Cancer (Dove Med Press)       Date:  2018-01-18

5.  Association of Cytochrome CYP1A1 Gene Polymorphisms and Tobacco Smoking With the Risk of Breast Cancer in Women From Iraq.

Authors:  Hassan M Naif; Mohammed A I Al-Obaide; Hayfa H Hassani; Abdualghani S Hamdan; Zainab S Kalaf
Journal:  Front Public Health       Date:  2018-04-11

6.  Red Clover Aryl Hydrocarbon Receptor (AhR) and Estrogen Receptor (ER) Agonists Enhance Genotoxic Estrogen Metabolism.

Authors:  Tareisha L Dunlap; Caitlin E Howell; Nita Mukand; Shao-Nong Chen; Guido F Pauli; Birgit M Dietz; Judy L Bolton
Journal:  Chem Res Toxicol       Date:  2017-10-19       Impact factor: 3.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.